Long-acting protein drugs for the treatment of ocular diseases

Retinal vascular disease treatments involve frequent pharmacological intraocular administrations. Here the authors present a method to increase the half-life of injected drugs by fusing these to a hyaluronan-binding peptide, which might lead to less frequent retinal disease treatments.

Guardado en:
Detalles Bibliográficos
Autores principales: Joy G. Ghosh, Andrew A. Nguyen, Chad E. Bigelow, Stephen Poor, Yubin Qiu, Nalini Rangaswamy, Richard Ornberg, Brittany Jackson, Howard Mak, Tucker Ezell, Vania Kenanova, Elisa de la Cruz, Ana Carrion, Bijan Etemad-Gilbertson, Roxana Garcia Caro, Kan Zhu, Vinney George, Jirong Bai, Radhika Sharma-Nahar, Siyuan Shen, Yiqin Wang, Kulandayan K. Subramanian, Elizabeth Fassbender, Michael Maker, Shawn Hanks, Joanna Vrouvlianis, Barrett Leehy, Debby Long, Melissa Prentiss, Viral Kansara, Bruce Jaffee, Thaddeus P. Dryja, Michael Roguska
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/f0adf43d440f4267b734d5d4506d7186
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f0adf43d440f4267b734d5d4506d7186
record_format dspace
spelling oai:doaj.org-article:f0adf43d440f4267b734d5d4506d71862021-12-02T14:42:05ZLong-acting protein drugs for the treatment of ocular diseases10.1038/ncomms148372041-1723https://doaj.org/article/f0adf43d440f4267b734d5d4506d71862017-03-01T00:00:00Zhttps://doi.org/10.1038/ncomms14837https://doaj.org/toc/2041-1723Retinal vascular disease treatments involve frequent pharmacological intraocular administrations. Here the authors present a method to increase the half-life of injected drugs by fusing these to a hyaluronan-binding peptide, which might lead to less frequent retinal disease treatments.Joy G. GhoshAndrew A. NguyenChad E. BigelowStephen PoorYubin QiuNalini RangaswamyRichard OrnbergBrittany JacksonHoward MakTucker EzellVania KenanovaElisa de la CruzAna CarrionBijan Etemad-GilbertsonRoxana Garcia CaroKan ZhuVinney GeorgeJirong BaiRadhika Sharma-NaharSiyuan ShenYiqin WangKulandayan K. SubramanianElizabeth FassbenderMichael MakerShawn HanksJoanna VrouvlianisBarrett LeehyDebby LongMelissa PrentissViral KansaraBruce JaffeeThaddeus P. DryjaMichael RoguskaNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Joy G. Ghosh
Andrew A. Nguyen
Chad E. Bigelow
Stephen Poor
Yubin Qiu
Nalini Rangaswamy
Richard Ornberg
Brittany Jackson
Howard Mak
Tucker Ezell
Vania Kenanova
Elisa de la Cruz
Ana Carrion
Bijan Etemad-Gilbertson
Roxana Garcia Caro
Kan Zhu
Vinney George
Jirong Bai
Radhika Sharma-Nahar
Siyuan Shen
Yiqin Wang
Kulandayan K. Subramanian
Elizabeth Fassbender
Michael Maker
Shawn Hanks
Joanna Vrouvlianis
Barrett Leehy
Debby Long
Melissa Prentiss
Viral Kansara
Bruce Jaffee
Thaddeus P. Dryja
Michael Roguska
Long-acting protein drugs for the treatment of ocular diseases
description Retinal vascular disease treatments involve frequent pharmacological intraocular administrations. Here the authors present a method to increase the half-life of injected drugs by fusing these to a hyaluronan-binding peptide, which might lead to less frequent retinal disease treatments.
format article
author Joy G. Ghosh
Andrew A. Nguyen
Chad E. Bigelow
Stephen Poor
Yubin Qiu
Nalini Rangaswamy
Richard Ornberg
Brittany Jackson
Howard Mak
Tucker Ezell
Vania Kenanova
Elisa de la Cruz
Ana Carrion
Bijan Etemad-Gilbertson
Roxana Garcia Caro
Kan Zhu
Vinney George
Jirong Bai
Radhika Sharma-Nahar
Siyuan Shen
Yiqin Wang
Kulandayan K. Subramanian
Elizabeth Fassbender
Michael Maker
Shawn Hanks
Joanna Vrouvlianis
Barrett Leehy
Debby Long
Melissa Prentiss
Viral Kansara
Bruce Jaffee
Thaddeus P. Dryja
Michael Roguska
author_facet Joy G. Ghosh
Andrew A. Nguyen
Chad E. Bigelow
Stephen Poor
Yubin Qiu
Nalini Rangaswamy
Richard Ornberg
Brittany Jackson
Howard Mak
Tucker Ezell
Vania Kenanova
Elisa de la Cruz
Ana Carrion
Bijan Etemad-Gilbertson
Roxana Garcia Caro
Kan Zhu
Vinney George
Jirong Bai
Radhika Sharma-Nahar
Siyuan Shen
Yiqin Wang
Kulandayan K. Subramanian
Elizabeth Fassbender
Michael Maker
Shawn Hanks
Joanna Vrouvlianis
Barrett Leehy
Debby Long
Melissa Prentiss
Viral Kansara
Bruce Jaffee
Thaddeus P. Dryja
Michael Roguska
author_sort Joy G. Ghosh
title Long-acting protein drugs for the treatment of ocular diseases
title_short Long-acting protein drugs for the treatment of ocular diseases
title_full Long-acting protein drugs for the treatment of ocular diseases
title_fullStr Long-acting protein drugs for the treatment of ocular diseases
title_full_unstemmed Long-acting protein drugs for the treatment of ocular diseases
title_sort long-acting protein drugs for the treatment of ocular diseases
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/f0adf43d440f4267b734d5d4506d7186
work_keys_str_mv AT joygghosh longactingproteindrugsforthetreatmentofoculardiseases
AT andrewanguyen longactingproteindrugsforthetreatmentofoculardiseases
AT chadebigelow longactingproteindrugsforthetreatmentofoculardiseases
AT stephenpoor longactingproteindrugsforthetreatmentofoculardiseases
AT yubinqiu longactingproteindrugsforthetreatmentofoculardiseases
AT nalinirangaswamy longactingproteindrugsforthetreatmentofoculardiseases
AT richardornberg longactingproteindrugsforthetreatmentofoculardiseases
AT brittanyjackson longactingproteindrugsforthetreatmentofoculardiseases
AT howardmak longactingproteindrugsforthetreatmentofoculardiseases
AT tuckerezell longactingproteindrugsforthetreatmentofoculardiseases
AT vaniakenanova longactingproteindrugsforthetreatmentofoculardiseases
AT elisadelacruz longactingproteindrugsforthetreatmentofoculardiseases
AT anacarrion longactingproteindrugsforthetreatmentofoculardiseases
AT bijanetemadgilbertson longactingproteindrugsforthetreatmentofoculardiseases
AT roxanagarciacaro longactingproteindrugsforthetreatmentofoculardiseases
AT kanzhu longactingproteindrugsforthetreatmentofoculardiseases
AT vinneygeorge longactingproteindrugsforthetreatmentofoculardiseases
AT jirongbai longactingproteindrugsforthetreatmentofoculardiseases
AT radhikasharmanahar longactingproteindrugsforthetreatmentofoculardiseases
AT siyuanshen longactingproteindrugsforthetreatmentofoculardiseases
AT yiqinwang longactingproteindrugsforthetreatmentofoculardiseases
AT kulandayanksubramanian longactingproteindrugsforthetreatmentofoculardiseases
AT elizabethfassbender longactingproteindrugsforthetreatmentofoculardiseases
AT michaelmaker longactingproteindrugsforthetreatmentofoculardiseases
AT shawnhanks longactingproteindrugsforthetreatmentofoculardiseases
AT joannavrouvlianis longactingproteindrugsforthetreatmentofoculardiseases
AT barrettleehy longactingproteindrugsforthetreatmentofoculardiseases
AT debbylong longactingproteindrugsforthetreatmentofoculardiseases
AT melissaprentiss longactingproteindrugsforthetreatmentofoculardiseases
AT viralkansara longactingproteindrugsforthetreatmentofoculardiseases
AT brucejaffee longactingproteindrugsforthetreatmentofoculardiseases
AT thaddeuspdryja longactingproteindrugsforthetreatmentofoculardiseases
AT michaelroguska longactingproteindrugsforthetreatmentofoculardiseases
_version_ 1718389846438838272